Arturo Sanchez - Medical Innovation CEO
CEO
Mr. Arturo Jake Sanchez was appointed as Chief Executive Officer, Director of the Company. Jake is a seasoned executive with extensive skills in operations, technology, PL oversight, direct and nondirect channel sales and marketing working with both startups and growth organizations. He is a results oriented leader with proven accomplishments in strategic positioning using process driven approach to manage and scale organizations. He comes with a track record of increasing revenue, driving down costs, growing the bottom line while driving up productivity. He has worked extensively in disruptive market opportunities where technology, regulations, and laws create havoc and change in existing markets allowing new players to enter the marketplace. Mr. Sanchez was founder and Chairman CEO of Planning Technologies, Inc. where he developed leadership tactics focused on growth and revenue. PTI was recognized as one of the nation premier leading providers of consulting and engineering services. The company grew under Mr. Sanchez leadership to include more than 200 employees serving a worldwide client base of Fortune 100 companies and U.S. government agencies. While working with the Veterans Administration Mr. Sanchez and his company designed, developed, integrated, and installed one of the first tele medicine applications for remote heart monitoring and diagnostics. Mr. Sanchez received his undergraduate degree in Finance and was a fouryear letterman in wrestling at Marshall University. since 2016.
| Age | 59 |
| Tenure | 8 years |
| Phone | 866-883-3793 |
| Web | http://medicalinnovationholdings.com |
Similar Executives
| Found 6 records | CEO Age | ||
| Mor Weizer | Playtech plc | 39 | |
| Richard Zimmerman | Cedar Fair LP | 63 | |
| Ivan Menezes | Diageo PLC ADR | 65 | |
| Anand Kripalu | Diageo PLC ADR | 59 | |
| Matthew Ouimet | Cedar Fair LP | 62 | |
| Amy Taylor | Zevia Pbc | 52 | |
Medical Innovation Leadership Team
Elected by the shareholders, the Medical Innovation's board of directors comprises two types of representatives: Medical Innovation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Innovation's management team and ensure that shareholders' interests are well served. Medical Innovation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Innovation's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Stol, Director | ||
| Redgie Green, Director | ||
| Arturo Sanchez, CEO | ||
| Bart Siegel, Director | ||
| Raymond Demotte, CFO, Director | ||
| Lawrence Litowitz, Interim CFO | ||
| Madhava Mankal, CFO and Director | ||
| Daniel Medina, CEO and President and Director | ||
| John Lewis, Director | ||
| Raimundo Dias, President Corporate Secretary, Director | ||
| Michael Gallo, Director |
Medical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Medical Innovation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 567.7 K | |||
| Shares Outstanding | 39.88 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Price To Earning | (22.61) X | |||
| Price To Sales | 4.15 X | |||
| Revenue | 48 K | |||
| Net Income | (1.43 M) | |||
| Cash And Equivalents | 6.46 K | |||
| Total Debt | 514.34 K | |||
| Book Value Per Share | (0.04) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medical Innovation in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medical Innovation's short interest history, or implied volatility extrapolated from Medical Innovation options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Medical Innovation information on this page should be used as a complementary analysis to other Medical Innovation's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Medical OTC BB Equity
If you are still planning to invest in Medical Innovation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medical Innovation's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |